Details for 2017194619

Up to date per 04.04.2026

Actions

Title / Product Name

AUF INDOLAMIN-2,3-DIOXYGENASE BASIERENDE IMMUNTHERAPIE

Status

Granted/Registered

Protection Type

European Patent

(AT-) Application Number

2017194619

EP Publication Number

3320912

E-Number

1376185

Language

PCT Number

Publication Date

16.05.2018 A

31.03.2021 B1

Registration Date

31.03.2021

AT Publication Date

15.04.2021

Application Date

17.04.2009

Registration Number

Priorities

17.04.2008

200800565

IPC

A61K 38/17 20060101AFI20180206BHEP

Maximum Duration of Protection

17.04.2029

Owner

IO BIOTECH ApSc/o COBIS Ole Maaløes Vej 3 2200 Copenhagen NDK

Representative

Patentanwaltskanzlei Matschnig & Forsthuber OGBiberstraße 221010 WienAT

Inventor

ANDERSEN, Mads HaldHegnsvej 61 2850 NærumDK

STRATEN, Per ThorCatherine Booths Vej 17 2650 HvidovreDK

Information about Fees